+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Targeted next generation sequencing reveals a novel intragenic deletion of the LAMA2 gene in a patient with congenital muscular dystrophy



Targeted next generation sequencing reveals a novel intragenic deletion of the LAMA2 gene in a patient with congenital muscular dystrophy



Molecular Medicine Reports 11(5): 3687-3693



Mutations in the LAMA2 gene cause laminin α‑2 (merosin)‑deficient congenital muscular dystrophies, which are autosomal recessive muscle disorders. Laminin α‑2 is widely expressed in the basement membrane of skeletal muscle, the myotendinous junctions and extra‑synaptically at neuromuscular synapses. In the present study, target next‑generation sequencing was used for mutation detection, and polymerase chain reaction (PCR) analysis and Sanger sequencing were used in the identification of small deletions. Subsequently, quantitative PCR (qPCR) was performed to characterize the identified deletion encompassing exon five of the LAMA2 gene. Two causative mutations were identified using target region sequencing which provided the additional information required to facilitate clinical diagnosis. One heterozygous mutation (p. Lys682LysfsX22) was identified and confirmed by Sanger sequencing, and another heterozygous mutation (Exon5del) was found and validated by qPCR. Co‑segregation analysis indicated that the Exon5del mutation originated from the proband's mother and the previously reported frameshift mutation (p. Lys682LysfsX22) was inherited from the proband's father. To the best of our knowledge, the present study was the first to report an entire exon five deletion in the LAMA2 gene.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058972849

Download citation: RISBibTeXText

PMID: 25544356

DOI: 10.3892/mmr.2014.3135


Related references

Targeted Next Generation Sequencing Identifies a Novel Deletion in LAMA2 Gene in a Merosin Deficient Congenital Muscular Dystrophy Patient. Indian Journal of Pediatrics 83(4): 354-355, 2016

Targeted next generation sequencing reveals novel splice site mutations in COL6A3 gene in a patient with congenital muscular dystrophy. Neurology India 66(6): 1812-1814, 2018

Targeted next generation sequencing reveals a novel intragenic deletion of the TPO gene in a family with intellectual disability. Archives of Medical Research 43(4): 312-316, 2012

A resolved discrepancy between multiplex PCR and multiplex ligation-dependent probe amplification by targeted next-generation sequencing discloses a novel partial exonic deletion in the Duchenne muscular dystrophy gene. Journal of Clinical Laboratory Analysis 32(8): E22575, 2018

Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. Febs Letters 415(1): 33-39, 1997

Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy. Journal of Medical Genetics 28(12): 860-864, 1991

Novel mutations identified in patients with mild phenotype of Ullrich congenital muscular dystrophy through targeted next-generation sequencing. 2013

A comprehensive genetic diagnosis of Chinese muscular dystrophy and congenital myopathy patients by targeted next-generation sequencing. Neuromuscular Disorders 25(8): 617-624, 2015

Identification of Two Novel LAMA2 Mutations in a Chinese Patient with Congenital Muscular Dystrophy. Frontiers in Genetics 9: 43, 2018

LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients. Clinical Genetics 74(6): 502-512, 2008

Novel LAMA2 Gene Mutations Associated with Merosin-Deficient Congenital Muscular Dystrophy. Iranian Biomedical Journal 22(6): 408-414, 2018

Novel compound heterozygous laminina2-chain gene (LAMA2) mutations in congenital muscular dystrophy. Human Mutation 12(2): 135, 1998

Novel mutations in LAMA2 gene responsible for a severe phenotype of congenital muscular dystrophy in two Tunisian families. Archives de l'Institut Pasteur de Tunis 83(1-4): 19-23, 2006

LAMA2 gene analysis in congenital muscular dystrophy: new mutations, prenatal diagnosis, and founder effect. Archives of Neurology 62(10): 1582-1586, 2005

Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. Journal of Biological Chemistry 271(44): 27664-9, 1996